Instructions for Itrazole (Itraconazole) 100 mg
English product name
Itrazol
Release form
Capsules
Description Itrazole:
Capsules solid gelatine,
№0, white color;
The contents of the capsules are pellets (spherical microgranules) of light yellow to brown yellow color.
1 cap.
Itraconazole (in pellet form) 100 mg
Auxiliary substances: sugar pellets (sucrose - 80-91.5%, corn starch - 8.5-20%) - 207.44 mg, poloxamer 188 (Lutrol) - 25.94 mg, poloxamer 188 (Lutrol) micronized - 0.51 mg, hypromellose - 130.11 mg.
Composition of hard gelatine capsules: titanium dioxide - 2%, gelatin - up to 100%.
Weight of capsule with contents - 560 mg.
6 pcs. - packages of box contour (1) - cardboard packs.
7 pcs. - packages of box contour (2) - cardboard packs.
7 pcs. - packages of box contour (6) - cardboard packs.
ATC codes
J02AC02 Itraconazole
Clinical-pharmacological groups / Group affiliation
Antifungal preparation
Active substance
itraconazole
Pharmacotherapy group
Antifungal agent
Storage Conditions
The drug Itraconazole should be stored in a place inaccessible to children, protected from light at a temperature not higher than 25 ° C.
Best before date
Shelf life is 2.5 years.
Testimony Itrazole:
- dermatomycosis;
- fungal keratitis;
- onychomycosis caused by dermatophytes and/or yeast and mold fungi;
- systemic mycosis: systemic aspergillosis and candidiasis, cryptococcosis (including cryptococcal meningitis), histoplasmosis, sporotrichosis, paracocydia idomycosis, blastomycosis and other systemic or tropical mycosis;
- Candidiasis with skin or mucous lesions (including vulvovaginal candidiasis);
- You're a moron.
Method of use, course and dosage:
Itrazol® should be taken inside, after eating.
Capsules should be swallowed whole.
Application for kidney disorders
Patients with kidney failure may require a dose correction.
Use in liver disorders
Patients with elevated liver enzyme activity or liver disease in the active phase or with a toxic liver injury when taking other drugs Itraconazole should not be treated with Itrazol unless the expected benefit justifies the risk of liver damage. In these cases, it is necessary to control the activity of hepatic enzymes during treatment.
Terms of Sale
The drug Itraconazole is prescription.
Use in children
It is contraindicated in children under 3 years of age.
Nosology (ICD codes)
B35.0
Mikoz beards and heads
B35.1
Nail mycosis
B35.2
Mikoz brushes
B35.3
Mycosis stop
B35.4
Torso mycosis
B35.6
Epidermofitia
B36.0
Multicolored fox
B37.0
Candidiasis stomatitis
B37.1
Pulmonary candidiasis
B37.2
Skin and nail candidiasis
B37.3
Candidiasis vulva and vagina
B37.4
Candidiasis of other urogenital localizations
B37.6
Candida endocarditis
B37.7
Candidiasis sepsis
B37.8
Candidiasis of other localizations (including candidiasis enteritis)
B38
Coccidioidomycosis
B39
Histoplasmosis
B40
Blastomycosis
B41
Paracocydiidomycosis
B42
Sporotrichosus
B43
Chromomycosis and theomytic abscess
B44
Aspergillosis
B45
Cryptococcosis
H19.2
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified in other headings
Pharmacological effect:
Antifungal drug Itraconazole.
Itraconazole is a synthetic broad-spectrum antifungal agent derived from triazole. Inhibits the synthesis of ergosterin cell membrane of fungi, which causes the antifungal effect of the preparation
